San Francisco Sentry Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q2 | – | Sell |
-19,240
| Closed | -$649K | – | 727 |
|
2021
Q1 | $649K | Hold |
19,240
| – | – | 0.28% | 99 |
|
2020
Q4 | $672K | Hold |
19,240
| – | – | 0.32% | 86 |
|
2020
Q3 | $668K | Hold |
19,240
| – | – | 0.34% | 77 |
|
2020
Q2 | $630K | Buy |
+19,240
| New | +$630K | 0.33% | 80 |
|
2018
Q2 | – | Sell |
-88
| Closed | -$2K | – | 838 |
|
2018
Q1 | $2K | Hold |
88
| – | – | ﹤0.01% | 860 |
|
2017
Q4 | $2K | Hold |
88
| – | – | ﹤0.01% | 852 |
|
2017
Q3 | $2K | Buy |
+88
| New | +$2K | ﹤0.01% | 856 |
|
2014
Q2 | – | Sell |
-12,000
| Closed | -$274K | – | 650 |
|
2014
Q1 | $274K | Hold |
12,000
| – | – | 0.09% | 176 |
|
2013
Q4 | $222K | Hold |
12,000
| – | – | 0.08% | 184 |
|
2013
Q3 | $203K | Hold |
12,000
| – | – | 0.08% | 188 |
|
2013
Q2 | $186K | Buy |
+12,000
| New | +$186K | 0.07% | 186 |
|